Grifols.
Spanish pharmaceutical company
- Reports this week
- 1
- Active events
- 1
- Connections
- 48
What's happening
Active this week
Earlier this month
-
Grifols, a plasma therapeutic company, operates in the US, Spain, and Canada, and MarketBeat is reporting on analyst recommendations for the company.Some support1 report
-
Gilead Sciences and Grifols traded on the NASDAQ stock exchange on September 8, 2026.Some support1 report
-
Health Canada found multiple deficiencies at Grifols sites, leading to a partnership established for collecting plasma for medicine.Some support2 reports2 developments inside
-
Grifols, Canadian Blood Services, and Health Canada are working on a framework for sustainable plasma collection.Some support1 report
One to three months ago
-
Ground zero for commercial paid plasma collection in Saskatchewan, facing scrutiny over standards.Some support1 report
-
Kissei partnership drives international sales of TAVALISSE, Rigel received $5 million from Grifols, and VEPPANU received FDA approval.Some support2 reports
-
Norges Bank and Royal Bank of Canada made new investment moves in Grifols.Some support1 report
-
Spanish companies, including Grifols and Técnicas Reunidas, participate in a Bahrain consortium amid geopolitical uncertainty and rising oil prices.Some support1 report
-
Grifols was listed on the Nasdaq stock exchange.Some support2 reports
-
BioPharma appoints a new US head and secures US plasma supply, while Grifols reorganizes its operating model.Some support1 report
Gone quiet
No new reports in 90+ days-
Seeking regulatory approval for a new therapy involving the FDA and Grifols.Some support1 report
-
Grifols and Indra Sistemas maintain operational presences in Spain and Europe.Well supported4 reports
-
Whirlpool, Creative Medical Technology Holdings, and Grifols faced downward revisions to their earnings estimates on July 31, 2025.Some support1 report
-
Neurocrine Biosciences and Grifols are both medical drugs stocks.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Grifols this week
News at the entities that move Grifols most-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Grifols
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Grifols
-
Health Canada StructuralHealth Canada approved the new indication for IMCIVREE, a product focused on the North American market, while Jennifer Lee serves as EVP for Rhythm.Moves Grifols
-
Bank of Montreal TransactionalInsider trading activities reported on September 28, 2026, include a Chair acquiring shares of BCE Inc., a Chief Risk Officer selling BMO shares, and a CEO purchasing Altus Group Ltd. shares.Moves Grifols
-
Norges Bank TransactionalNorges Bank bought a new position in Qualcomm shares, coinciding with buy ratings and price targets from TD Cowen, reported by MarketBeat.Moves Grifols
-
Royal Bank of Canada TransactionalRoyal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Moves Grifols
Connections
The 17 strongest of 48, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Grifols is formally listed on the Nasdaq stock exchange, establishing a market dependency.
-
FDA Structural
The FDA exercises formal regulatory oversight over Grifols' development and market access applications.
-
Roland Structural
Roland serves as the President of Grifols.
-
Health Canada Structural
Health Canada exercises formal regulatory oversight over Grifols, issuing non-compliance notices and suspending operations.
-
Canadian Blood Services Operational
The entities maintain a high-stakes operational partnership for plasma collection, which is simultaneously facing competitive challenges and calls for contract termination.
-
Norges Bank Transactional
Norges Bank acquired a new financial position in Grifols shares.
-
Bank of Montreal Transactional
Bank of Montreal increased its financial stake in Grifols.
-
Pablo García Structural
Pablo García holds the role of director in Divacons, which is a company that is part of the Grifols corporate structure.
Show all 17 connections
-
Royal Bank of Canada Transactional
Royal Bank of Canada increased its financial stake in Grifols.
-
Stevanato Group Operational
Grifols is actively compared to Stevanato Group based on superior earnings outlook and valuation metrics.
-
Brookfield Transactional
Brookfield was involved in speculation and considered a takeover bid for Grifols.
-
Spain Shared context
Grifols is a Spanish pharmaceutical company that operates and is headquartered within Spain.
-
Catalonia Shared context
Grifols is a company whose establishment is rooted in the region of Catalonia.
-
Saskatchewan Shared context
Grifols operates plasma clinics within the jurisdiction of Saskatchewan.
-
MarketBeat Mentioned together
MarketBeat provides summarized ratings and financial coverage for Grifols.
-
BioPharma Shared context
Both companies operate within the same highly regulated US life sciences market, specifically regarding plasma supply and operational models.
-
WhiteBox Transactional
WhiteBox decreased its stake in Grifols shares.
History
Events by the month they beganSeptember 2026
3 events- Grifols, a plasma therapeutic company, operates in the US, Spain, and Canada, and MarketBeat is reporting on analyst recommendations for the company.
- Gilead Sciences and Grifols traded on the NASDAQ stock exchange on September 8, 2026.
- Grifols, Canadian Blood Services, and Health Canada are working on a framework for sustainable plasma collection.
August 2026
5 events- Canadian Blood Services faces union calls for contract termination after Health Canada issued a non-compliance rating.
- Ground zero for commercial paid plasma collection in Saskatchewan, facing scrutiny over standards.
- Kissei partnership drives international sales of TAVALISSE, Rigel received $5 million from Grifols, and VEPPANU received FDA approval.
- Norges Bank and Royal Bank of Canada made new investment moves in Grifols.
- Spanish companies, including Grifols and Técnicas Reunidas, participate in a Bahrain consortium amid geopolitical uncertainty and rising oil prices.
July 2026
1 eventShow 1 earlier month
June 2026
6 events- Health Canada found multiple deficiencies at Grifols sites, leading to a partnership established for collecting plasma for medicine.
- Grifols was listed on the Nasdaq stock exchange.
- Seeking regulatory approval for a new therapy involving the FDA and Grifols.
- Grifols and Indra Sistemas maintain operational presences in Spain and Europe.
- Whirlpool, Creative Medical Technology Holdings, and Grifols faced downward revisions to their earnings estimates on July 31, 2025.
- Neurocrine Biosciences and Grifols are both medical drugs stocks.